🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

10 recruiting trials

for Blepharoptosis

Anterior Versus Posterior White Line Advancement Technique in the Correction of Aponeurotic Ptosis NCT07003308NA1 site📍 Móstoles Instituto de Investigación Sanitaria de la Fundación Jiméne… · Tests: Anterior White Line Advancement Surgery, Posterior White Line Advancement Surgery A Study in Chinese Patients With Acquired Blepharoptosis NCT06683651Phase 323 sites📍 Hefei📍 Hefei📍 Beijing Santen Pharmaceutical Co., Ltd. · Tests: STN1013800 ophthalmic solution, STN1013800 ophthalmic solution Liquid Base, without STN1013800 Natural History of Oculo-Pharyngeal Muscular Dystrophy (OPMD) - Israel National OPMD Registry NCT07146256n/a1 site📍 Ramat Gan Sheba Medical Center · Tests: Non-interventional observational study Capturing Key MG-symptoms Using Smartphone Recordings. NCT06743490n/a2 sites📍 Leiden📍 Leiden Leiden University Medical Center A Prospective Cohort Study on Visual Function and Psychological Conditions Before and After Surgery for Congenital Ptosis NCT07534436n/a1 site📍 Guangzhou Zhongshan Ophthalmic Center, Sun Yat-sen University Comparative Study of Ziplyft Treatment vs. Traditional Blepharoplasty for Upper Eyelid Rejuvenation NCT07250139NA1 site📍 Oxford Osheru Inc. · Tests: Ziplyft Device, Comparator Arm: Standard Blepharoplasty LIDRISE Study: A Phase 3 Study on the Efficacy and Safety of STN1013800 (Oxymetazoline HCl 0.1% Eye Drops, Single Dose) in the Treatment of Acquired Blepharoptosis. NCT06514612Phase 336 sites📍 Pardubice📍 Pilsen📍 Prague Santen SAS · Tests: STN1013800 (0.1% Oxymetazoline Hydrochloride) eye drops in single dose containers, Placebo (0% Oxymetazoline Hydrochlor… A Feedback-enabled Magnetic Device for Temporary Management of Blepharoptosis NCT03812016NA2 sites📍 Kaohsiung City📍 Taipei E-DA Hospital · Tests: Feedback-enabled magnetic device Blepharoptosis After Repeated Intravitreal Anti-VEGF Injections: A Prospective Study NCT07821450n/a1 site📍 Istanbul Abdulkadir Küçük · Tests: Repeated intravitreal anti-VEGF injection with eyelid speculum Spacer Graft Study NCT04140734NA1 site📍 The Bronx Montefiore Medical Center · Tests: Spacer Graft
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy